LINCOLN PHARMACEUTICALS LTD. - 531633 - Closure of Trading Window
Intimation of Closure of Trading Window.28-09-2023
28-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs08-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication For Notice of 29th Annual General Meeting08-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs06-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs06-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 (1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''the SEBI Listing Regulations''), we are submitting herewith the Annual Report of the Company along with the Notice of Twenty Ninth Annual General Meeting (''AGM'') for the Financial Year 2022-2023.06-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Notice Of 29Th Annual General Meeting Of The Company.
29th Annual General Meeting ("AGM") of the Members of the Company will be held on Saturday, 30th September, 2023 at 11:00 A.M (IST) through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM"), in accordance with relevant circulars issued by Ministry of Corporate Affairs and Security and Exchange Board of India. We hereby enclose the notice of 29th Annual general Meeting of the Company which is being sent to the members through electronic mode.06-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs04-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs04-09-2023
LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs29-08-2023